Stuart A Arbuckle Immuno Gen, Inc. (IMGN) insider trading activity

Stuart A Arbuckle is Director of ImmunoGen, Inc.. Currently has a direct ownership of 0 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Feb 12, 2024, when has been sold 5,381 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Stuart A Arbuckle Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 12 2024	SELL Sale (or disposition) back to the issuer	-	5,381 Reduced 100.0%	0 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$13,105 $29.65 p/Share	442 Added 7.59%	5,381 Common Stock
Sep 29 2023	BUY Grant, award, or other acquisition	$13,124 $15.87 p/Share	827 Added 14.34%	4,939 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$13,114 $18.87 p/Share	695 Added 14.46%	4,112 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	$13,121 $3.84 p/Share	3,417 Added 50.0%	3,417 Common Stock

Also insider at

VRTX

VERTEX PHARMACEUTICALS INC Healthcare

EVP, COO

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

Director

SAA